|
Cardiovascular Disease/ Myocardial Infarction
Citations 121-130 of 1017 total displayed.
|
Past content
(since Feb 1998):
|
- Clinical Reviews
Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease: A Meta-analysis of Randomized Trials
- Jeffrey S. Berger; Mori J. Krantz; John M. Kittelson; William R. Hiatt
JAMA 2009; 301: 1909-1919.
[Abstract]
[Full text]
[PDF]
- Editorials
Aspirin and Secondary Prevention in Peripheral Artery Disease: A Perspective for the Early 21st Century
- Mary McGrae McDermott; Michael H. Criqui
JAMA 2009; 301: 1927-1928.
[Extract]
[Full text]
[PDF]
- JAMA Classics
Assessing Authority
- Drummond Rennie; Iain Chalmers
JAMA 2009; 301: 1819-1821.
[Extract]
[Full text]
[PDF]
[ Original Article ]
- Health Agencies Update
New Aspirin Recommendations
- Bridget M. Kuehn
JAMA 2009; 301: 1647-b.
[Extract]
[Full text]
[PDF]
- Letters
Equivalence of Generic and Brand-Name Drugs for Cardiovascular Disease
- Michael James Zema
JAMA 2009; 301: 1654-a-1655-a.
[Extract]
[Full text]
[PDF]
- Letters
Equivalence of Generic and Brand-Name Drugs for Cardiovascular Disease
- Barry L. Carter
JAMA 2009; 301: 1654.
[Extract]
[Full text]
[PDF]
- Letters
Equivalence of Generic and Brand-Name Drugs for Cardiovascular Disease—Reply
- Aaron S. Kesselheim; Alexander S. Misono; William H. Shrank
JAMA 2009; 301: 1655-a-1656-a.
[Extract]
[Full text]
[PDF]
- Letters
Equivalence of Generic and Brand-Name Drugs for Cardiovascular Disease
- James A. Reiffel
JAMA 2009; 301: 1655.
[Extract]
[Full text]
[PDF]
- Letters
Rapid Response Team Implementation and Hospital Mortality Rates
- John H. Sherner
JAMA 2009; 301: 1658-a-1659-a.
[Extract]
[Full text]
[PDF]
- Letters
Rapid Response Team Implementation and Hospital Mortality Rates
- Stuart F. Reynolds; Rinaldo Bellomo; Ken Hillman
JAMA 2009; 301: 1659.
[Extract]
[Full text]
[PDF]
|
|
